April, 2024
April 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
David Steensma: Our proteomics analysis of the large CANTOS CV trial is now online Blood Advances
Nov 12, 2023, 17:42

David Steensma: Our proteomics analysis of the large CANTOS CV trial is now online Blood Advances

David Steensma, Chief Medical Officer of Ajax Therapeutics, posted on X/Twitter.

“Our proteomics analysis of the large CANTOS CV trial is now online Blood Advances led by Janghee Woo (now Winship Cancer Institute of Emory). Clonal hematopoiesis was associated with incident anemia and markers of inflammation which were attenuated by IL-1b inhibitor therapy.”

Source: David Steensma/X